This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2013
Title: The Innovative Contributions of Magnus Sellstedt
Introduction
Magnus Sellstedt is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address serious health conditions.
Latest Patents
Sellstedt holds a patent for peptidomimetic compounds. The present invention relates to new compounds of the formula (I), (II), or (III) wherein R, R, R, R, R, and W are as defined herein. These compounds are part of pharmaceutical compositions that are used in the treatment of amyloid diseases, especially Aβ amyloid disease, which is observed in Alzheimer's disease, infectious diseases, and PAI-I related diseases. The invention also pertains to the manufacture of medicaments for such treatments.
Career Highlights
Throughout his career, Sellstedt has focused on innovative solutions in the pharmaceutical industry. His work has the potential to impact the treatment of various amyloid-related diseases, showcasing his commitment to advancing medical science.
Collaborations
Sellstedt has collaborated with notable professionals in his field, including Fredrik Almqvist and Pralay Das. These partnerships have likely contributed to the success of his research and patent developments.
Conclusion
Magnus Sellstedt's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing compounds for the treatment of amyloid diseases is a testament to his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile